Host-Response Diagnostics

Delivering precision medicine on demand


TEDx Palo Alto:
The power of reading the immune system to better diagnose disease

Dr. Tim Sweeney, Inflammatix Co-Founder and CEO

Our tests are addressing significant clinical needs in acute infection and sepsis diagnosis that affect millions of people


In the News: Game Changing Impact

Recent notable news stories

November 15, 2019

Inflammatix Nabs $6M from BARDA to Develop POC Acute Infection Diagnostic

Link to story

November 14, 2019

Inflammatix scores BARDA contract for infection tests

Link to story

September 20, 2019

AACC panel votes Inflammatix technology most disruptive

Link to story

August 16, 2019

Inflammatix Preps Immune-Response Sepsis Dx for FDA Clinical Trial, Lays Out Future Test Plans

Link to story

Also covered by


Stay in touch with Twitter updates: Find out the latest news.

Connect with Twitter